Physician profile
Nathan Andrew Eberle
NPI 1760541130
$5,874.93
in general payments reported to CMS, 2019-2025
13 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,145 · 2020: $188 · 2021: $1,394 · 2022: $364 · 2023: $82.14 · 2024: $295 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642 · Gift: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.14 |
| Gift | $140.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,084.47 | 2019-2022 | |
| Straumann USA LLC | $1,780.87 | 2019-2025 | |
| Mentor Worldwide LLC | $307.55 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Zimvie INC. | $216.65 | 2022 | |
| Ultradent Products INC | $140.97 | 2024 | Opalescence |
| Revance Therapeutics, INC. | $111.53 | 2025 | Daxxify |
| Integra Lifesciences Corporation | $73.82 | 2025 | Integra, Surgimend, Omnigraft |
| Galderma Laboratories, L.P. | $57.53 | 2022-2025 | |
| Sientra, INC. | $33.50 | 2022 | |
| Solventum Corporation | $21.08 | 2024 | Prevena, Attest |
| Coopersurgical, INC. | $20.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.62 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $10.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Eberle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.